← All peptidesPDA-V1 attestation Used in protocols Citations
warningBioGate · AMBERGrade B
Selank
TKPRPGPSynthetic heptapeptide based on tuftsin; modulates GABAergic and serotonergic tone via BDNF upregulation.
intranasal formulation
MW
751.85
Length
7aa
Posterior
54.5%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · intranasal formulation
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 5
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
1
Participants
165
Mean Δ
+1.09
Δ HRV ms (8-week) · 95% CI [0.53, 1.66]
IPNFT - Not minted
This peptide is not currently represented as an IPNFT. Cohort outcomes feed back into the unminted pool.
Where this peptide shows up.
Source literature.
Grade C2003 · Bull Exp Biol Med
Selank and short peptides of the tuftsin family in correction of stress
Kozlovskaya MM et al.